Staphylococcus aureus in cystic fibrosis: implications for prognosis and treatment.
Döring
G
G
Department of General and Environmental Hygiene, University of Tübingen, Germany.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D013211:Staphylococcus aureus / Q000302:isolation & purification / Q000472:pathogenicity; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents